BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Flolan (Epoprostenol) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Flolan (Epoprostenol)\, from ClinicalTria
 ls.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07837869-523@assetmemo.bio
DTSTAMP:20261121T005713Z
DTSTART;VALUE=DATE:20280229
DTEND;VALUE=DATE:20280301
SUMMARY:Flolan (Epoprostenol): Phase 1/2 readout est. (NCT07837869)
DESCRIPTION:Flolan (Epoprostenol)\, phase 1/2.\nStudy: PACE: Prostacyclin A
 ntiCoagulation in ECMO\nEstimated primary completion: February 2028. This 
 is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it c
 an move.\nDrug page: https://assetmemo.bio/drug/epoprostenol#upcoming-even
 ts\nRegistry record: https://clinicaltrials.gov/study/NCT07837869
URL:https://assetmemo.bio/drug/epoprostenol#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05450328-523@assetmemo.bio
DTSTAMP:20261121T005713Z
DTSTART;VALUE=DATE:20280501
DTEND;VALUE=DATE:20280502
SUMMARY:Flolan (Epoprostenol): Phase 2 readout est. (NCT05450328)
DESCRIPTION:Flolan (Epoprostenol)\, phase 2.\nStudy: Inhaled Milrinone and 
 Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Sepa
 ration\nEstimated primary completion: 1 May 2028. This is a ClinicalTrials
 .gov estimate\, not a confirmed readout date\, and it can move.\nDrug page
 : https://assetmemo.bio/drug/epoprostenol#upcoming-events\nRegistry record
 : https://clinicaltrials.gov/study/NCT05450328
URL:https://assetmemo.bio/drug/epoprostenol#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07424378-523@assetmemo.bio
DTSTAMP:20261121T005713Z
DTSTART;VALUE=DATE:20281130
DTEND;VALUE=DATE:20281201
SUMMARY:Flolan (Epoprostenol): Phase 4 readout est. (NCT07424378)
DESCRIPTION:Flolan (Epoprostenol)\, phase 4.\nStudy: Epoprostenol Plus Conv
 entional Therapy in COld and Frostbite Injury (ECCO)\nEstimated primary co
 mpletion: November 2028. This is a ClinicalTrials.gov estimate\, not a con
 firmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/d
 rug/epoprostenol#upcoming-events\nRegistry record: https://clinicaltrials.
 gov/study/NCT07424378
URL:https://assetmemo.bio/drug/epoprostenol#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
